Complete Responses in the TEMPI Syndrome after Treatment with Daratumumab

To the Editor: First described in 2011, the TEMPI syndrome is a rare multisystem disease characterized by telangiectasias, an elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric fluid collections, and intrapulmonary shunting. Treatment with bortezomib led to partial…

https://ift.tt/2l8wbyh